Description

6-(4-Bromophenyl)-2-(2-Hydroxy-4,5-Dihydro-3H-1-Benzazepin-3-Yl)Pyridazin-3(2H)-One is a high-purity, advanced pharmaceutical intermediate designed for research and development. This compound is valued for its complex heterocyclic structure, which serves as a critical building block in modern medicinal chemistry. It is primarily utilized by pharmaceutical companies and research institutions engaged in the synthesis of novel therapeutic agents, particularly in the areas of central nervous system (CNS) and cardiovascular drug discovery.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel active pharmaceutical ingredients (APIs) targeting specific biological pathways.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new drug candidates.
• CNS Drug Development: Serves as a core scaffold for compounds being investigated for neurological and psychiatric disorders.
• Cardiovascular Agent Synthesis: Employed in the research and development of potential therapeutic agents for heart-related conditions.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services.
• Academic Research: Utilized in university and institutional labs for pharmacological studies and chemical methodology development.

Basic Information

Product Name	6-(4-Bromophenyl)-2-(2-Hydroxy-4,5-Dihydro-3H-1-Benzazepin-3-Yl)Pyridazin-3(2H)-One
CAS No.	1224160-08-0
Molecular Formula	C22H18BrN3O2
Molecular Weight	436.30 g/mol
Synonyms	6-(4-Bromophenyl)-2-(2-hydroxy-4,5-dihydro-3H-1-benzazepin-3-yl)pyridazin-3(2H)-one; 2-(2-Hydroxy-4,5-dihydro-3H-1-benzazepin-3-yl)-6-(4-bromophenyl)pyridazin-3(2H)-one; 1224160-08-0; 3H-1-Benzazepin-3-ol, 4,5-dihydro-2-[6-(4-bromophenyl)-3-oxo-3,4-dihydro-2-pyridazinyl]-; 6-(p-Bromophenyl)-2-(2-hydroxy-4,5-dihydro-3H-1-benzazepin-3-yl)pyridazin-3(2H)-one
EINECS	Contact for details

Quality Control

Our 6-(4-Bromophenyl)-2-(2-Hydroxy-4,5-Dihydro-3H-1-Benzazepin-3-Yl)Pyridazin-3(2H)-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with every shipment, detailing all critical specifications. Our quality commitment supports compliance with cGMP guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to ensure maximum stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.